Mills drops out of Maine U.S. Senate race
Maine Gov. Janet Mills announced she would suspend her campaign in the race for U.S. Senate on Thursday.
Mills was one of the top contenders for the Democratic nomination against incumbent Republican Sen. Susan Collins, R-Maine. Now, Graham Platner, an oyster farmer, appears poised to be the frontrunner for the competitive Democratic nomination.
Mills said she did not have the financial resources to continue her campaign in a statement posted to social media Thursday.
“While I have the drive and passion, commitment and experience, and above all else – the fight – to continue on, I very simply do not have the one thing that political campaigns unfortunatley require today: the financial resources,” Mills wrote.
Mills did not endorse another candidate in the Democratic primary for the competitive U.S. Senate Race in Maine.
Platner has faced controversy over past comments and a tattoo some have recognized as resembling a Nazi symbol.
Senate Minority Leader Chuck Schumer, D-N.Y., and Kirsten Gillebrand, head of the Senate Democrat’s campaign arm, said they would work to support Platner’s campaign against Sen. Collins.
“After years of allowing Trump’s abuses of power, Senator Collins has never been more vulnerable and we will work with the presumptive Democratic nominee Graham Platner to defeat her,” Schumer wrote in a statement.
Maine’s primary election is set for June 9.
Latest News Stories
‘Long overdue’: Praise for HHS’ action to bar taxpayer-funded sex-change procedures
Gas prices drop, but taxes make Illinois pricier than Midwest neighbors
Recruit Firefighters Jace Cook and Braeden Waterman Graduate
Liquor License Amendments Approved for Frankfort, Joliet, and Lockport Businesses
Meeting Summary and Briefs: Will County Planning and Zoning Commission for December 16, 2025
Joliet Property Owner Cleared to Convert Non-Conforming Building into Two-Unit Residence
Meeting Summary and Briefs: Washington Township Board of Trustees for Nov. 2025
Colorado adopts first-of-its-kind water protections in U.S.
Epstein files redactions frustrate lawmakers
Nine pharmaceutical companies agree to most-favored-nation pricing
Congress leaves for holidays after zero progress on federal funding
EXCLUSIVE: New House committee report highlights increasing terrorism threat in U.S.